[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.166.22. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 553
Citations 0
Correction
June 2014

Incorrect Information in Abstract

JAMA Neurol. 2014;71(6):803. doi:10.1001/jamaneurol.2014.1559

In the article titled “Correlation of Parkinson Disease Severity and 18F-DTBZ Positron Emission Tomography” published online April 21, 2014, and in the June issue of JAMA Neurology (2014;71[6]:758-766. doi:10.1001/jamaneurol.2014.290), incorrect information appeared. The second sentence of the Results section in the abstract should have read, “The mean reductions of vesicular monoamine transporter type 2 density for the caudate, putamen, and substantia nigra were 21.50%, 58.20%, and 21.10% for mild PD [Parkinson disease]; 60.75%, 79.49%, and 39.87% for moderate PD; and 63.94%, 83.20%, and 44.00% for advanced PD, respectively” instead of “The mean reductions of vesicular monoamine transporter type 2 density for the caudate, putamen, and substantia nigra were 27.29%, 63.26%, and 31.03% for mild PD; 61.76%, 81.54%, and 48.41% for moderate PD; and 81.78%, 89.47%, and 66.62% for advanced PD, respectively.” This article was corrected online.

×